Lv1
20 积分 2023-06-18 加入
NK Cells Mediate T-cell Inflammation in the Tumor Microenvironment
1个月前
已完结
Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade
1个月前
已完结
Longitudinal Plasma Metabolomics Guides Dynamic Risk Assessment and Dietary Modulation for Esophageal Squamous Cell Cancer Chemoimmunotherapy
2个月前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
3个月前
已完结
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus Immunotherapy and targeted therapy in HCC
4个月前
已完结
Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
4个月前
已完结
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
5个月前
已完结
MEF2D-expressing cancer precursors reprogram tissue-resident macrophages to support liver tumorigenesis
6个月前
已完结
Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers
6个月前
已完结
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
7个月前
已完结
皖公网安备34019202002308
